425: Strive CRO Posts on X Regarding Semler Merger

Strive, Inc. Chief Risk Officer Jeff Walton posted on X.com regarding the company's proposed business combination with Semler Scientific, Inc., highlighting the ongoing merger process and associated risks.

Summary

• Strive, Inc. filed a Form 425 related to its proposed business combination with Semler Scientific, Inc.
• The filing includes a communication posted on X.com by Jeff Walton, Strive's Chief Risk Officer, on December 4, 2025.
• The communication pertains to the proposed merger and includes extensive cautionary statements regarding forward-looking information.
• The transaction involves Strive issuing additional shares of its Class A common stock.
• A Registration Statement on Form S-4, including an Information Statement/Proxy Statement/Prospectus, has been filed with the SEC to register the shares and seek stockholder approval.

Sentiment

Score: 6

Explanation: The filing is primarily procedural for a merger, which is generally a positive strategic move. However, it contains extensive and standard cautionary language regarding forward-looking statements and numerous risks, which tempers the overall sentiment to moderately positive, reflecting the inherent uncertainties of such transactions.

Positives

• The companies are actively progressing with the proposed business combination.
• The filing indicates ongoing communication regarding the merger, including a public post by Strive's CRO.

Risks

• The proposed transaction may not close when expected or at all if conditions to closing are not met or satisfied on a timely basis.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• Integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact outcomes.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including a positive impact on the combined company's future financial performance. They expect the transaction to close, but acknowledge that the timing and successful integration are subject to various risks and uncertainties.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., posted a communication on X.com on December 4, 2025, regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

This filing is a standard procedural step in a corporate merger, common across various industries. The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests Strive or the combined entity may operate in or be exposed to the digital asset space, which is a growing trend in financial and corporate strategy.

Corporate Governance

Legal Proceedings

• The possibility that legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.

Stakeholder Impact

• Shareholders: Semler Scientific stockholders will vote on the merger and receive Strive Class A common stock, potentially experiencing dilution. Strive shareholders will also experience dilution.
• Customers: Potential for adverse reactions or changes to business relationships.
• Employees: Potential for changes to employee relationships.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will vote on the proposed transaction.
• The proposed transaction will close upon satisfaction of conditions.
• Integration of the combined businesses will occur post-closing.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury, Digital Assets, Corporate Governance, Proxy Solicitation